Avedro

Avedro is a private medical device and pharmaceutical company dedicated to advancing the science and technology of corneal cross-linking. Avedro recently completed its multicenter Phase III corneal cross-linking study in the United States for the treatment of progressive keratoconus and corneal ectasia after refractive surgery. Outside the United States, Avedro has commercialized VibeX and its KXL system for performing Lasik Xtra and accelerated cross-linking. Additionally, Avedro is developing thermal biomechanical science for therapeutic medical applications.